Cargando…
SARS-CoV-2 Neutralizing Antibody Levels Post COVID-19 Vaccination Based on ELISA Method—A Small Real-World Sample Exploration
This study investigated the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) neutralizing antibodies following inoculation with the coronavirus disease (COVID-19) vaccine. From June to July 2021, 127 participants who had completed COVID-19 vaccination (inactivated SARS-CoV-2...
Autores principales: | Li, Xiaoguang, Liang, Chao, Xiao, Xiumei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541171/ https://www.ncbi.nlm.nih.gov/pubmed/34696247 http://dx.doi.org/10.3390/vaccines9101139 |
Ejemplares similares
-
Clinical performances of an ELISA for SARS-CoV-2 antibody assay and correlation with neutralization activity
por: Padoan, Andrea, et al.
Publicado: (2020) -
An ELISA Platform for the Quantitative Analysis of SARS-CoV-2 RBD-neutralizing Antibodies As an Alternative to Monitoring of the Virus-Neutralizing Activity
por: Kostin, N. N., et al.
Publicado: (2022) -
Evaluation of a commercial ELISA as alternative to plaque reduction neutralization test to detect neutralizing antibodies against SARS-CoV-2
por: Hofmann, Natalie, et al.
Publicado: (2022) -
A novel competition ELISA for the rapid quantification of SARS‐CoV‐2 neutralizing antibodies in convalescent plasma
por: Wouters, Elise, et al.
Publicado: (2021) -
Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection
por: Tan, Yun, et al.
Publicado: (2020)